The genetic polymorphisms of CYP1A1/1B1,which lead to altered metabolic activity, are associated with the risk of cancer orother premalignant diseases in the human uterus, cervix, vagina and colorectaltissue [5-9]. Here, CYP1A1 is linked to cancer.